NRC Health Property, Plant and Equipment, Gross
NRC Health (NRC) had Property, Plant and Equipment, Gross of $81.98 million as of 2025-09-30, per its 10-Q filed 2025-11-07.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2025-11-07
- 2025-09-30: Property, Plant and Equipment, Gross $81.98M.
- 2025-06-30: Property, Plant and Equipment, Gross $80.70M.
- 2025-03-31: Property, Plant and Equipment, Gross $77.22M.
- 2024-12-31: Property, Plant and Equipment, Gross $73.65M.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2025-09-30 | $81.98M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $80.70M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $77.22M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $73.65M 10-Q · filed 2025-11-07 |
| 2024-09-30 | $76.32M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $72.29M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $68.61M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $63.87M 10-Q · filed 2024-11-08 |
| 2023-09-30 | $62.77M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $58.95M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $54.35M 10-Q · filed 2023-05-05 |
| 2022-12-31 | $50.76M 10-K · filed 2024-02-27 |
| 2022-09-30 | $52.18M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $49.30M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $47.34M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $45.60M 10-K · filed 2023-03-03 |
| 2021-09-30 | $46.42M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $45.23M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $44.09M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $42.70M 10-K · filed 2022-03-04 |
| 2020-09-30 | $45.14M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $43.48M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $42.44M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $42.08M 10-K · filed 2021-03-05 |
| 2019-09-30 | $48.24M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $47.09M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $45.89M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $44.73M 10-K · filed 2020-03-06 |
| 2018-09-30 | $45.09M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $43.22M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $41.40M 10-Q · filed 2018-05-04 |
| 2017-12-31 | $40.21M 10-K · filed 2019-03-08 |
| 2017-09-30 | $41.18M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $40.21M 10-Q · filed 2017-08-04 |
| 2017-03-31 | $39.19M 10-Q · filed 2017-05-05 |
| 2016-12-31 | $37.89M 10-K · filed 2018-03-14 |
| 2016-09-30 | $37.82M 10-Q · filed 2016-11-04 |
| 2016-06-30 | $37.06M 10-Q · filed 2016-08-05 |
| 2016-03-31 | $35.93M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $34.59M 10-K · filed 2017-03-03 |
| 2015-09-30 | $34.28M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $35.63M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $34.73M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $34.73M 10-K · filed 2016-03-04 |
| 2014-09-30 | $34.52M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $34.03M 10-Q · filed 2014-08-06 |
| 2014-03-31 | $32.87M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $32.33M 10-K · filed 2015-03-04 |
| 2013-09-30 | $32.78M 10-Q · filed 2013-11-07 |
| 2013-06-30 | $32.13M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $31.56M 10-Q · filed 2013-05-08 |
| 2012-12-31 | $31.19M 10-K · filed 2014-03-04 |
| 2012-09-30 | $31.11M 10-Q · filed 2012-11-07 |
| 2012-06-30 | $30.43M 10-Q · filed 2012-08-10 |
| 2011-12-31 | $29.23M 10-K · filed 2013-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |